AMGN Technical Analysis

As of date:	7/22/2021
AMGN stock price:	244.74
AMGN 50 DMA:	243.29
AMGN 200 DMA:	236.34
AMGN MACD (200-50):	-6.95
AMGN RSI:	43.82

Extremely Overbought
	43.82
Extremely Oversold

Also see:
AMGN Market Cap History
AMGN Shares Outstanding History
AMGN YTD Return

Quotes delayed 20 minutes

Get Free SEC filing alerts for AMGN:
AMGN SEC Filing Email Alerts Service

Weis Markets Breaks Below 200-Day Moving Average - Notable for WMK
1 hour, 15 minutes ago

iShares Currency Hedged MSCI Emerging Markets Breaks Below 200-Day Moving Average - Notable for HEEM
1 hour, 16 minutes ago

Notable Two Hundred Day Moving Average Cross - CCK
1 hour, 16 minutes ago

GATX Shares Cross Below 200 DMA
1 hour, 16 minutes ago

HSC Crosses Below Key Moving Average Level
1 hour, 16 minutes ago

PGJ Crosses Critical Technical Indicator
1 hour, 17 minutes ago

ProShares ProShares Short QQQ (PSQ) Enters Oversold Territory
1 hour, 17 minutes ago

SCHE Crosses Below Key Moving Average Level
1 hour, 22 minutes ago

Notable Two Hundred Day Moving Average Cross - EEM
1 hour, 22 minutes ago

TMQ.CA Makes Notable Cross Below Critical Moving Average
1 hour, 22 minutes ago

NPI.CA Crosses Above Key Moving Average Level
1 hour, 23 minutes ago

WASH Makes Notable Cross Below Critical Moving Average
19 hours, 16 minutes ago

Cadence Bancorporation (CADE) Shares Cross Below 200 DMA
20 hours, 3 minutes ago

RLI Makes Notable Cross Below Critical Moving Average
20 hours, 16 minutes ago

Notable Two Hundred Day Moving Average Cross - EVLO
Thursday, July 22, 11:38 AM

More Technical Analysis News

Amgen is a biotechnology company that discovers, develops, manufactures and delivers human therapeutics. Co.'s products include: Enbrel® (etanercept), which is used in indications for the treatment of adult patients with moderately to severely active rheumatoid arthritis, patients with chronic moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy and patients with active psoriatic arthritis; and Prolia® (denosumab), which it is used for the treatment of postmenopausal women with osteoporosis at high risk of fracture or multiple risk factors for fracture; or in patients who have failed or are intolerant to other available osteoporosis therapy.

When researching a stock like Amgen, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from AMGN Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for AMGN stock — the real life supply and demand for the stock over time — and examines that data in different ways.

10 Most Oversold S&P 500 Stocks

10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying

10 ETFs With Most Upside To Targets

The DividendRank Top 25

Warren Buffett Dividend Stocks

10 Cheap Dividend Stocks Under $10

10 Top DividendRank'ed Energy Stocks

The 10 Highest Yielding Preferred Stocks

The 15 Most Active S&P Call & Put Options

Video: Technical Analysis

If the video does not load after a few moments, Upgrade to the Latest Flash Player.

Amgen (AMGN) is categorized under the Healthcare sector; to help you further research Technical Analysis, below are some other companies in the same sector:

BAX Technical Analysis
BDX Technical Analysis
BIIB Technical Analysis
BMY Technical Analysis
BSX Technical Analysis
CAH Technical Analysis
CELG Technical Analysis
CNC Technical Analysis
COO Technical Analysis
DGX Technical Analysis
More Healthcare companies »

Nothing in TechnicalAnalysisChannel.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.

AMGN Technical Analysis | www.TechnicalAnalysisChannel.com | Copyright © 2019 - 2021, All Rights Reserved